BioMed Central
Book and Periodical PublishingEngland, United Kingdom501-1000 Employees
BioMed Central is a publisher focused on open access research publishing, committed to innovation and safeguarding the integrity of the research it disseminates. Based in London, England, it operates within the book and periodical publishing sector as a mid-sized organization. Its portfolio includes journals such as Genome Biology and Genome Medicine, along with specialized titles like Malaria Journal and Microbiome, spanning about 65 journals that serve diverse research communities; it also publishes journals on behalf of partner institutions and societies. The company also manages the UK primary clinical trial registry ISRCTN, reflecting its role in supporting transparent clinical research. In 2024, it announced a collaboration with Symphony Bio to develop cancer treatments that harness the immune system using an orbiting laboratory.